四维彩超联合促甲状腺激素在诊断甲状腺癌中临床价值［摘要］目的评价高频彩超联合促甲状腺激素在甲状腺癌诊断中的价值，进一步提高诊断准确率，减少误、漏诊率。方法分析2010年1月〜2011年12月在我院就诊的甲状腺癌患者45例，将上述患者按照随机对照原则分为A组（25例）和B组（20例），其中A组患者术前进行彩超诊断，B组患者术前进行四维彩超联合促甲状腺激素诊断，对两组患者的诊断率进行比较。结果A组患者彩超诊断甲状腺癌14例（56.0%）,未能确定良恶性6例（24.0%）,误诊为良性病变5例（20.0%）oB组患者四维彩超联合促甲状腺激素诊断甲状腺癌18例（90.0%）,未能确定良恶性1例（5.0%）,误诊为良性病变1例（5.0%）。两组患者之间诊断率比较，差异具有统计学意义（x2=6.252,P<0.05）o结论甲状腺癌的超声表现具有一定的特征性，应用四维彩超联合促甲状腺激素诊断甲状腺癌具有重要的临床价值。［关键词］四维彩超；促甲状腺激素；甲状腺癌；诊断［中图分类号］R736.1［文献标识码］B［文章编号］1673-7210（2012）07（c）-0098-02Valueoffour-dimensionalcolorDopplerultrasoundcombinedwiththyroidstimulatinghormoneindiagnosisDepartmentofFirstSurgery,QishiHospitalofDongguanCity,GuangdongProvince,Dongguan523500,ofthyroidcancerGANXiaohaiZENGXianming[Abstract]ObjectiveToevaluatehighfrequencyultrasonographycombinedwithTSHinthyroidcancerChinadiagnosistofurtherimprovetheaccuracyofdiagnosis,reduceerrorandtherateofmisseddiagnosis・Methods45casespatientswiththyroidcancerfromJanuary2010toDecember2011inourhospitalwereanalyzed・ThepatientsaccordingtotherandomandcontrolprincipledividedintogroupA(n二25)andgroupB(n=20).GroupAwerediagnosedbycolorDopplerultrasoundbeforeoperation,whilegroupBwerediagnosedbypreoperativefour-dimensionedcolorDopplerultrasoundcombinedwithTSHdiagnosis・Thencomparedthediagnosisrateoftwogroupsofpatients.ResultsIntheAgroup,patientswithcolorDopplerultrasoundindiagnosisofthyroidcarcinomawere14cases(56%).Filingtoidentifybenignandmalignantwere6cases(24%)・5casesweremisdiagnosedasbenignlesion(20%)・ThepatientsintheBgroupfour-dimensionalcolorDopplerultrasoundcombinedwithTSHindiagnosisofthyroidcarcinomawere18cases(90%)・Filingtoidentifybenignandmalignantwas1case(5%)・1casewasmisdiagnosedasbenignlesion(5%)・Therewasstatisticaldifferencebetweentwogroups(%2二6.252,P<0.05)・ConclusionThyroidcarcinomawithultrasonographyhascertaincharacteristics.Four-dimensionalcolorDopplerultrasoundcombinedwithTSHindiagnosisofthyroidcancerhasimportantclinicalvalue・[Keywords]Four-dimensionalcolorDopplerultrasound；TSH；ThyroidCancer；Diagniosis甲状腺癌是人体内分泌系统中最为常见的恶性肿瘤，占全身恶性肿瘤的1%〜5%[1]。近年来，甲状腺癌的术前检出率呈现逐年提高的趋势[2]。本文分析我院2010年1月〜2011年12月收治的45例甲状腺癌患者的彩超及四维彩超联合促甲状腺激素(thyrotropin,thyroidstimulatinghormone,TSH)表现，旨在提高甲状腺癌的早期诊断率，对指导临床手术以及提高患者的预后生存具有重要意义。